 Connection
Amrut Ambardekar to Retrospective Studies
This is a "connection" page, showing publications Amrut Ambardekar has written about Retrospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.284 |
|
|
|
-
Ambardekar AV, Hunter KS, Babu AN, Tuder RM, Dodson RB, Lindenfeld J. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study. Circ Heart Fail. 2015 Sep; 8(5):944-52.
Score: 0.039
-
Herod JW, Ambardekar AV. Right ventricular systolic and diastolic function as assessed by speckle-tracking echocardiography improve with prolonged isolated left ventricular assist device support. J Card Fail. 2014 Jul; 20(7):498-505.
Score: 0.036
-
Ambardekar AV, Dorosz JL, Cleveland JC, Lindenfeld J, Buttrick PM. Longitudinal left ventricular structural and functional imaging during full support with continuous-flow ventricular assist devices: a retrospective, preliminary analysis. J Heart Lung Transplant. 2012 Dec; 31(12):1311-3.
Score: 0.033
-
Ambardekar AV, Walker JS, Walker LA, Cleveland JC, Lowes BD, Buttrick PM. Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Fail. 2011 Jul; 4(4):425-32.
Score: 0.029
-
Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC, Brieke A, Sauer WH. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010 Jul; 29(7):771-6.
Score: 0.027
-
Ambardekar AV, Lowery CM, Allen LA, Cannon AP, Cleveland JC, Lindenfeld J, Brieke A, Sauer WH. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Card Fail. 2010 Apr; 16(4):327-31.
Score: 0.027
-
Suarez-Pierre A, Zakrzewski J, Anigbogu C, Iguidbashian JP, Ziogas IA, Peters LL, Ambardekar AV, Hoffman JR, Reece TB, Cleveland JC, Rove JY. Prolonged travel time to transplantation center is associated with poor outcomes following heart transplantation. Am J Surg. 2024 02; 228:279-286.
Score: 0.018
-
Oreschak K, Saba LM, Rafaels N, Ambardekar AV, Deininger KM, PageII R, Lindenfeld J, Aquilante CL. Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients. J Heart Lung Transplant. 2021 09; 40(9):917-925.
Score: 0.015
-
Hughes DL, Rice JD, Burton JR, Jin Y, Peterson RA, Ambardekar AV, Pomposelli JJ, Pomfret EA, Kriss MS. Presence of any degree of coronary artery disease among liver transplant candidates is associated with increased rate of post-transplant major adverse cardiac events. Clin Transplant. 2020 11; 34(11):e14077.
Score: 0.014
-
Oreschak K, Wolfel EE, Saba LM, Ambardekar AV, Lindenfeld J, Aquilante CL. Relationship between nocturnal blood pressure patterns and end organ damage and diastolic dysfunction in heart transplant recipients. Clin Transplant. 2020 05; 34(5):e13842.
Score: 0.014
-
Cobretti MR, Page RL, Linnebur SA, Deininger KM, Ambardekar AV, Lindenfeld J, Aquilante CL. Medication regimen complexity in ambulatory older adults with heart failure. Clin Interv Aging. 2017; 12:679-686.
Score: 0.011
-
Bryant BM, Libby AM, Metz KR, Page RL, Ambardekar AV, Lindenfeld J, Aquilante CL. Evaluating Patient-Level Medication Regimen Complexity Over Time in Heart Transplant Recipients. Ann Pharmacother. 2016 11; 50(11):926-934.
Score: 0.011
-
Deininger KM, Vu A, Page RL, Ambardekar AV, Lindenfeld J, Aquilante CL. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients. Clin Transplant. 2016 09; 30(9):1074-81.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|